DTaP-IPV vaccine

Source: Wikipedia, the free encyclopedia.
DTaP-IPV vaccine
Inactivated poliovirus vaccine
Vaccine
Clinical data
Trade namesKinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
Other namesdiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
AHFS/Drugs.comKinrix Quadracel
Pregnancy
category
  • AU: A
Intramuscular injection
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number

DTaP-IPV vaccine is a

inactivated poliovirus vaccine (IPV).[1][2]

It is also known as

poliomyelitis.[1]

Branded formulations marketed in the USA are

Quadracel from Sanofi Pasteur.[4]

Repevax is available in the UK.[5][6]

Within Japan, the formulation is called 四種混合(shishukongou - "mixture of 4"). Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').[7][8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.[9]

References

  1. ^ a b c "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
  2. PMID 31444785
    .
  3. US Food and Drug Administration
    . Retrieved 15 July 2018.
  4. US Food and Drug Administration
    . Retrieved 15 July 2018.
  5. ^ "Repevax, suspension for injection, in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)". www.medicines.org.uk. Retrieved 31 December 2020.
  6. ISBN 978-0-85711-369-6
    .
  7. ^ "医療用医薬品 : テトラビック (テトラビック皮下注シリンジ)". www.kegg.jp. Retrieved 2021-02-27.
  8. ^ "医療用医薬品 : クアトロバック (クアトロバック皮下注シリンジ)". www.kegg.jp. Retrieved 2021-02-27.
  9. ^ "【武田薬品】４種混合ワクチンの開発中止-ノロウイルスなどに資源投入｜薬事日報ウェブサイト". 9 February 2015. Retrieved 2021-02-27.
Retrieved from "https://en.wikipedia.org/w/index.php?title=DTaP-IPV_vaccine&oldid=1225147459"